You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Why Are Cancer Drugs So Expensive in the United States, and What Are the Solutions?
|
|---|---|
| Published in |
Mayo Clinic Proceedings, March 2015
|
| DOI | 10.1016/j.mayocp.2015.01.014 |
| Pubmed ID | |
| Authors |
Hagop Kantarjian, S. Vincent Rajkumar |
| Abstract |
High cancer drug prices are a worsening trend in cancer care and are affecting patient care and our health care system. In the United States, the average price of cancer drugs for about a year of therapy increased from $5000 to $10,000 before 2000 to more than $100,000 by 2012, while the average household income has decreased by about 8% in the past decade. Further, although 85% of cancer basic research is funded through taxpayers' money, Americans with cancer pay 50% to 100% more for the same patented drug than patients in other countries. Bound by the Hippocratic Oath, oncologists have a moral obligation to advocate for affordable cancer drugs. In this article, we discuss the high cost of cancer drugs, the reasons for these high prices, the implications for patients and the health care system, and potential solutions to the problem. |
X Demographics
The data shown below were collected from the profiles of 172 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 79 | 46% |
| Spain | 4 | 2% |
| United Kingdom | 3 | 2% |
| Canada | 3 | 2% |
| Mexico | 2 | 1% |
| Bahrain | 1 | <1% |
| India | 1 | <1% |
| Egypt | 1 | <1% |
| Puerto Rico | 1 | <1% |
| Other | 8 | 5% |
| Unknown | 69 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 125 | 73% |
| Practitioners (doctors, other healthcare professionals) | 21 | 12% |
| Scientists | 19 | 11% |
| Science communicators (journalists, bloggers, editors) | 7 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 130 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 18 | 14% |
| Researcher | 17 | 13% |
| Student > Doctoral Student | 13 | 10% |
| Student > Bachelor | 13 | 10% |
| Other | 10 | 8% |
| Other | 27 | 20% |
| Unknown | 35 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 11% |
| Social Sciences | 7 | 5% |
| Economics, Econometrics and Finance | 7 | 5% |
| Business, Management and Accounting | 6 | 5% |
| Other | 32 | 24% |
| Unknown | 41 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 272. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2023.
All research outputs
#131,904
of 25,393,528 outputs
Outputs from Mayo Clinic Proceedings
#116
of 5,151 outputs
Outputs of similar age
#1,443
of 277,965 outputs
Outputs of similar age from Mayo Clinic Proceedings
#3
of 59 outputs
Altmetric has tracked 25,393,528 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.6. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,965 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.